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Abstract: Purpose: Amygdalar metabolic activity was shown to independently predict cardiovascular
outcomes. However, little is known about age- and sex-dependent variability in neuronal stress re-
sponses among individuals free of cardiac disease. This study sought to assess age- and sex-specific differ-
ences of resting amygdalar metabolic activity in the absence of clinical cardiovascular disease. Methods:
Amygdalar metabolic activity was assessed in 563 patients who underwent multimodality imaging by
18F-fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography and echocar-
diography for the evaluation of cardiac function. Results: After exclusion of 294 patients with structural
or functional cardiovascular pathologies, 269 patients (128 women) remained in the final population.
18F-FDG amygdalar activity significantly decreased with age in men (r = - 0.278, P = 0.001), but not
in women (r = 0.002, P = 0.983). Similarly, dichotomous analysis confirmed a lower amygdalar activity
in men ฀ 50 years as compared to those < 50 years of age (0.79 ± 0.1 vs. 0.84 ± 0.1, P = 0.007),
which was not observed in women (0.81 ± 0.1 vs. 0.82 ± 0.1, P = 0.549). Accordingly, a fully adjusted
linear regression analysis identified age as an independent predictor of amygdalar activity only in men
(B-coefficient - 0.278, P = 0.001). Conclusion: Amygdalar activity decreases with age in men, but not
in women. The use of amygdalar activity for cardiovascular risk stratification merits consideration of
inherent age- and sex-dependent variability. Keywords: 18F-fluorodeoxyglucose (18F-FDG); Amygdala;
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Purpose. Amygdalar metabolic activity was shown to independently predict cardiovascular
outcomes. However, little is known about age- and sex-dependent variability in neuronal stress
responses among individuals free of cardiac disease. This study sought to assess age- and sex-
specific differences of resting amygdalar metabolic activity in the absence of clinical cardio-
vascular disease.
Methods. Amygdalar metabolic activity was assessed in 563 patients who underwent
multimodality imaging by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomogra-
phy/computed tomography and echocardiography for the evaluation of cardiac function.
Results. After exclusion of 294 patients with structural or functional cardiovascular
pathologies, 269 patients (128 women) remained in the final population.
18
F-FDG amygdalar
activity significantly decreased with age in men (r = 2 0.278, P = 0.001), but not in women
(r = 0.002, P = 0.983). Similarly, dichotomous analysis confirmed a lower amygdalar activity in
men ‡ 50 years as compared to those < 50 years of age (0.79 ± 0.1 vs. 0.84 ± 0.1, P = 0.007),
which was not observed in women (0.81 ± 0.1 vs. 0.82 ± 0.1, P = 0.549). Accordingly, a fully
adjusted linear regression analysis identified age as an independent predictor of amygdalar
activity only in men (B-coefficient 2 0.278, P = 0.001).
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Conclusion. Amygdalar activity decreases with age in men, but not in women. The use of
amygdalar activity for cardiovascular risk stratification merits consideration of inherent age-
and sex-dependent variability." 1"
Key Words: Amygdala Æ aging Æ sex differences Æ heart-brain axis Æ emotional stress Æ 18F-
fluorodeoxyglucose (18F-FDG) Æ positron emission tomography (PET) Æ echocardiography Æ
cardiovascular disease Æ risk stratification
INTRODUCTION
Cardiovascular disease remains the primary cause
of death in Europe, accounting for mortality rates of
49% and 40% in women and men, respectively.1 In
particular, there is increasing evidence for sex differ-
ences in the pathophysiology of coronary artery disease
(CAD), including the female propensity towards non-
obstructive CAD, coronary microvascular dysfunction,
and stress (Takotsubo) cardiomyopathy, thus prompting
reassessment of traditional cardiovascular risk condi-
tions.2 As such, considerable efforts have been devoted
to understand how emotional stress is translated into
adverse cardiovascular outcomes.
The brain’s salience network, an ensemble of inter-
connected brain regions responsible for emotional stress
responses, has recently gained increasing attention within
the context of CAD. Indeed, a recent landmark study
demonstrated that the resting amygdalar metabolic activ-
ity, a key element of the brain’s salience network,
independently predicted cardiovascular outcomes.3 Fur-
ther, increased amygdalar activity was linked to impaired
myocardial perfusion and function in women, but not in
men, which is in agreement with the higher incidence of
stress cardiomyopathy in women.4,5 Despite the detri-
mental association of enhanced amygdalar activity in
CAD patients, little is known about neuronal stress
responses in individuals free of cardiac disease. Under-
standing how the resting amygdalar activity is affected by
age and sex in the absence of cardiac disease, however, is
crucial for accurate risk assessment in CAD patients.
Thus, we sought to assess age- and sex-specific differ-
ences of amygdalar metabolic activity in individuals free
of clinical cardiovascular disease.
METHODS AND RESULTS
A total of 563 patients underwent clinically indicated
oncologic whole-body 18F-fluorodeoxyglucose (18F-FDG)
positron emission tomography (PET)/computed tomogra-
phy (CT) and echocardiography to assess cardiac function
according to current guidelines.6 After exclusion of 294
patients with impaired left ventricular ejection fraction
(LVEF\ 50%), presence of wall-motion abnormalities,
history of coronary artery disease (PCI, CABG, previous
myocardial infarction), and/or diabetes, 269 patients (128
[48%] women) free of clinical cardiovascular disease
remained in the final study population. None of these
patients had metabolically active malignancies. After
measurement of patient’s blood glucose level (5.5 ± 1.2
mmol/L inwomen and 5.8 ± 1.4mmol/L inmen,P = 0.11
for women vs. men), a dose of* 350 MBq 18F-FDG was
injected into a peripheral vein. Following tracer injection,
individualswere allowed to rest for 45-60 minutes before a
standardized PET image acquisition protocol, which
includes non-contrast CT, was applied. Whole-body scans
were cropped for the skull and quantitative assessment of
resting amygdalar activity was performed as previously
described.4 Briefly, serial regions of interest (ROI) were
placed in both amygdalae to measure 18F-FDG standard-
ized uptake value (SUV) by use of PMOD software V4.1
(PMOD Technologies LLC, Zurich, Switzerland) and
application of the brain maximum probability map (Ham-
mersmith atlas,7). Normalization was performed against
cerebellar activity. PET/CT and echocardiography were
performed within a maximum time frame of 3 months.
Pearson’s r was applied to investigate associations,
whereas linear regression models were used to identify
predictor variables. The study was reviewed and approved
by the institutional review board (BASEC No. 2017-
01112). The ethics committee waived the need for
informed consent due to the retrospective study design.
As depicted in Table 1, patient baseline character-
istics were comparable between women and men, with
the exceptions of smoking (women vs. men, 9.4% vs.
20.6%, P = 0.011), left ventricular ejection fraction
(LVEF, women vs. men, 62.9 ± 5.5 vs. 60.7 ± 6.0,
P = 0.002), and creatinine levels (women vs. men,
85.1 ± 79.2 vs. 118.4 ± 97.5, P = 0.028). The mean age
was 57.4 ± 16.3 years in women and 59.0 ± 13.5 years
in men. Pearson’s r correlation analysis showed a weak
and negative association between age and 18F-FDG
amygdalar uptake in the whole study population (r = -
0.132, P = 0.030, Figure 1A). When stratified by sex,
this relation was not observed in women (r = 0.002,
P = 0.983, Figure 1B), but was pronounced and inverse
in men (r = - 0.278, P = 0.001, Figure 1C). Dichoto-
mous analysis confirmed a significantly lower
amygdalar activity in men C 50 years as compared to
those \ 50 years of age (0.79 ± 0.1 vs. 0.84 ± 0.1,
P = 0.007, Figure 2A). In contrast, there was no differ-
ence in amygdalar activity in women C 50 vs. \ 50
years of age (0.81 ± 0.1 vs. 0.82 ± 0.1, P = 0.549,
Figure 2B). Stepwise linear regression analysis for 18F-
FDG amygdalar uptake as a dependent variable and age,
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hypertension, dyslipidemia, obesity, positive family
history for CAD, or smoking as predictor variables
identified age as sole independent predictor for amyg-
dalar activity in men (B-coefficient - 0.278, P = 0.001).
In the whole study population, an interaction term
consisting of age and male sex was selected as an
independent predictor for amygdalar activity in a linear
regression model (B-coefficient - 0.200, P = 0.001).
DISCUSSION
Taken together, we observed age- and sex-depen-
dent alterations of amygdalar activity in individuals free
of clinical cardiovascular disease. While amygdalar
activity significantly decreased with age in men, women
showed no age-related changes in amygdalar activity.
Accordingly, age was selected as an independent neg-
ative predictor of amygdalar activity in men, but not in
women. These findings imply that the use of resting
amygdalar metabolic activity for cardiovascular risk
stratification, as suggested in a recent landmark study by
Tawakol et al,3 merits careful consideration of age and
sex as potential confounders.
Chronic psychosocial stress is an established car-
diovascular risk factor. Nonetheless, the mechanisms
that translate emotional stress into cardiovascular events
remain poorly understood.8 Among the suggested mech-
anisms, the concept that increased amygdalar activity
results in enhanced hematopoiesis in the bone marrow,
thus contributing to arterial inflammation and subse-
quent worsening of CAD is particularly intriguing.3,9
Our study implies that amygdalar metabolic activity is











Age (years), mean±SD 58.2 ± 14.9 57.4 ± 16.3 59.0 ± 13.5 0.397
Hypertension, n(%) 82 (30.5) 39 (30.5) 43 (30.5) 1.000
Dyslipidemia, n(%) 18 (6.7) 7 (2.6) 11 (4.1) 0.475
Obesity, n(%) 39 (14.5) 19 (14.8) 20 (14.2) 1.000
Family history of CAD, n(%) 3 (1.1) 1 (0.8) 2 (1.4) 1.000
Smoking, n(%) 41 (15.2) 12 (9.4) 29 (20.6) 0.011
Alcohol, n(%) 18 (6.7) 6 (4.7) 12 (8.5) 0.232
LVEF (%), mean±SD 61.2 ± 5.8 62.9 ± 5.5 60.7 ± 6.0 0.002
Blood glucose (mmol/l), mean±SD 5.6 ± 1.3 5.5 ± 1.2 5.8 ± 1.4 0.105
Creatinine (lmol/l), mean±SD 102.3 ± 90.4 85.1 ± 79.2 118.4 ± 97.5 0.028
CRP (mg/l), mean±SD 53.5 ± 68.8 47.0 ± 66.6 59.2 ± 70.8 0.302
NT-proBNP (ng/l), mean±SD 1553 ± 2468 1204 ± 2524 2018 ± 2418 0.398
Neutrophils (x103/ll), mean±SD 5.8 ± 3.5 6.2 ± 4.1 5.5 ± 2.9 0.237
Lymphocytes (x103/ll), mean±SD 1.3 ± 0.8 1.4 ± 0.8 1.3 ± 0.7 0.159
18F-FDG bone marrow (SUV), mean±SD 1.9 ± 0.5 1.9 ± 0.5 1.9 ± 0.5 0.434
18F-FDG amygdala (rSUV), mean±SD 0.8 ± 0.1 0.8 ± 0.1 0.8 ± 0.1 0.388
ACE, n(%) 38 (14.2) 20 (15.6) 18 (12.9) 0.600
ARBs, n(%) 38 (14.2) 17 (13.3) 21 (15.1) 0.728
Beta blockers, n(%) 65 (24.3) 30 (23.4) 35 (25.2) 0.777
Loop diuretics, n(%) 41 (15.4) 18 (14.1) 23 (16.5) 0.613
ASS, n(%) 52 (19.5) 23 (18.0) 29 (20.9) 0.643
Antidepressants, n(%) 31 (11.6) 16 (12.5) 15 (10.8) 0.705
Statin, n(%) 42 (15.7) 21 (16.4) 21 (15.1) 0.867
Corticosteroids 66 (24.7) 35 (27.3) 31 (22.3) 0.395
ACE/ARBs, angiotensin converting enzyme/angiotensin II receptor blockers; ASS, acetylsalicylic acid; CAD, coronary artery
disease; CRP, C-reactive protein; 18F-FDG, 18F-fluorodeoxyglucose; LVEF, left ventricular ejection fraction; NT-proBNP, N-terminal
pro-B-type natriuretic peptide; SD, standard deviation; SUV, standardized uptake value; rSUV, relative standardized uptake value.
Data are presented as mean ± SD or frequencies (percentage). Two-sided P-values are indicated
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attenuated in elderly men, but not in elderly women,
suggesting that women exhibit a persistently high
neuronal stress level at older age. It is therefore tempting
to hypothesize that chronic activation of the brain’s
salience network might predispose women to a higher
cardiovascular vulnerability in situations of increased
demand such as an acute coronary syndrome (ACS).
Indeed, recent data indicate that women perceive greater
emotional stress following an ACS and are more likely
to develop mental-stress induced ischemia than men.10
Both observations emphasize the urgent need to account
for psychosocial factors in primary and secondary
prevention in women.2,11,12
As with any study, certain inherent design limita-
tions should be pointed out. First, this study is a single-
center retrospective analysis conducted in a cohort of
aged individuals, which limits its generalizability.
Second, our study is purely observational, and causality
cannot be inferred from the associations shown. Third,
although a comprehensive group of adjustment variables
was employed, unmeasured factors affecting amygdalar
metabolic activity, such as subclinical CADandother non-
detected cardiovascular conditions, as well as baseline
differences between men and women, may have affected
our endpoints. Fourth, given that patients were not
specifically referred for assessment of cardio-neurological
associations, a potential selection bias cannot be com-
pletely ruled out. Accordingly, the findings of this study
are to be considered as hypothesis-generating and need to
be confirmed in larger and, ideally, prospective studies.
In conclusion, our findings highlight that naturally
occurring age- and sex-dependent changes need to be
taken into consideration when using resting amygdalar
activity as a risk stratification tool in patients with
suspected or known CAD. Whether there is a direct link
between adverse cardiovascular outcomes and chronic
activation of the brain’s salience network in aging
women will have to be assessed in future studies.
Figure 1. Correlation of amygdalar activity with age. A Pearson product-moment correlation
reveals a gradual decline of amygdala metabolism during the aging process (P = 0.030) in the
whole study population. C When stratified by sex, this correlation was significant in men
(P = 0.001). B No correlation of amygdalar activity with age was observed in women (P = 0.983).
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Amygdalar metabolic activity declines with age in
men, but not in women. Naturally occurring age- and
sex-dependent changes in amygdalar metabolic activity
need to be taken into consideration when using this
metric as a risk stratification tool for patients with
suspected or known CAD.
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